Literature DB >> 34156509

Inter-reader reliability of contrast-enhanced ultrasound Liver Imaging Reporting and Data System: a meta-analysis.

Ji Hun Kang1, Sang Hyun Choi2, Ji Sung Lee3,4, Dong Wook Kim5, Jong Keon Jang5.   

Abstract

PURPOSE: To systematically determine the inter-reader reliability of the contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS), with emphasis on its major features for hepatocellular carcinoma (HCC) and LR-M (LI-RADS category M) features for non-HCC malignancy.
METHODS: MEDLINE, EMBASE, and Cochrane databases were searched from January 2016 to March 2021 to identify original articles reporting the inter-reader reliability of CEUS LI-RADS. Meta-analytic pooled kappa values (κ) were calculated for major features [nonrim arterial-phase hyperenhancement (APHE), mild and late washout], LR-M features (rim APHE, early washout), and LI-RADS categorization using the DerSimonian-Laird random-effects model. Meta-regression analysis was performed to explore any causes of study heterogeneity.
RESULTS: Twelve studies with a total of 2862 lesions were included. The meta-analytic pooled κ of nonrim APHE, mild and late washout, rim APHE, early washout, and LI-RADS categorization were 0.73 [95% confidence interval (CI), 0.67 - 0.79], 0.69 (95% CI, 0.54-0.84), 0.54 (95% CI, 0.37-0.71), 0.62 (95% CI, 0.45-0.79), and 0.75 (95% CI, 0.64-0.87), respectively. Compared with the major features, LR-M features had a lower meta-analytic pooled κ. Substantial study heterogeneity was noted in the LI-RADS categorization, and lesion size (p = 0.03) and the homogeneity in reader experience (p = 0.03) were significantly associated with study heterogeneity.
CONCLUSIONS: CEUS LI-RADS showed substantial inter-reader reliability for major features and LI-RADS categorization, but relatively lower reliability was found for LR-M features. In our opinion, the definitions of imaging features require further refinement to improve the inter-reader reliability of CEUS LI-RADS.

Entities:  

Keywords:  Hepatocellular carcinoma; Liver; Meta-analysis; Reproducibility of results; Ultrasonography

Year:  2021        PMID: 34156509     DOI: 10.1007/s00261-021-03169-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  31 in total

1.  Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.

Authors:  Eleonora Terzi; Massimo Iavarone; Maurizio Pompili; Letizia Veronese; Giuseppe Cabibbo; Mirella Fraquelli; Laura Riccardi; Ludovico De Bonis; Angelo Sangiovanni; Simona Leoni; Maria Assunta Zocco; Sandro Rossi; Nicola Alessi; Stephanie R Wilson; Fabio Piscaglia
Journal:  J Hepatol       Date:  2017-11-11       Impact factor: 25.083

2.  LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.

Authors:  Donald G Mitchell; Jordi Bruix; Morris Sherman; Claude B Sirlin
Journal:  Hepatology       Date:  2014-12-12       Impact factor: 17.425

3.  Accuracy of contrast-enhanced ultrasound liver imaging reporting and data system: a systematic review and meta-analysis.

Authors:  Jung Hee Son; Sang Hyun Choi; So Yeon Kim; So Jung Lee; Seong Ho Park; Kyung Won Kim; Hyung Jin Won; Yong Moon Shin; Pyo-Nyun Kim
Journal:  Hepatol Int       Date:  2020-11-10       Impact factor: 6.047

4.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

5.  The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.

Authors:  JiaWu Li; WenWu Ling; Shuang Chen; Lin Ma; Lulu Yang; Qiang Lu; Yan Luo
Journal:  Eur J Radiol       Date:  2019-10-07       Impact factor: 3.528

6.  Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosing hepatocellular carcinoma: A meta-analysis.

Authors:  Jaeseung Shin; Sunyoung Lee; Heejin Bae; Yong Eun Chung; Jin-Young Choi; Yong-Min Huh; Mi-Suk Park
Journal:  Liver Int       Date:  2020-08-08       Impact factor: 5.828

7.  Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.

Authors:  Hyo-Jin Kang; Jeong Min Lee; Jeong Hee Yoon; Kyoungbun Lee; Haeryoung Kim; Joon Koo Han
Journal:  Radiology       Date:  2020-08-04       Impact factor: 11.105

8.  Interobserver agreement for contrast-enhanced ultrasound of liver imaging reporting and data system: A systematic review and meta-analysis.

Authors:  Jun Li; Ming Chen; Zi-Jing Wang; Shu-Gang Li; Meng Jiang; Long Shi; Chun-Li Cao; Tian Sang; Xin-Wu Cui; Christoph F Dietrich
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

9.  Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.

Authors:  Hyo Jin Kang; Jeong Min Lee; Jeong Hee Yoon; Joon Koo Han
Journal:  Korean J Radiol       Date:  2020-11-03       Impact factor: 3.500

10.  Subtraction improves the accuracy of coronary CT angiography for detecting obstructive disease in severely calcified segments.

Authors:  Lixue Xu; Fang Li; Kewei Wu; Zhaohui Zhong; Rongchong Huang; Yinghao Xu; Zhenchang Wang; Zhenghan Yang; Yi He
Journal:  Eur Radiol       Date:  2021-06-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.